Education


Have a Question?

You can pose a question to the speaker by clicking on the "Suggest a Question" icon at the end of the session title. Appropriate questions will be answered during the session as time permits (not all questions will be answered).

Quick Search

You can use the search box below to locate specific speakers or sessions.



View Track: Luncheon Presentations

Luncheon Presentations
Tuesday, March 29, 2011
Suggest A Question for this Session
Cell Therapies: Commercializing a New Class of Biopharmaceuticals
Room: 1E18, 1E19, 1E20 ~ 12:30 pm - 2:00 pm (Tuesday, March 29, 2011)
Presented by:

Sponsored By: BioProcess International

Cell Therapies hold the promise of improving the quality and ultimately the lifespan of patients stricken with some of the world’s most challenging diseases and medical conditions. Manufacturers have the unique advantage of learning from the successes (and failures) of protein-based manufacturers – which could ultimately shave off years from their development and manufacturing timetables.

Based upon BioProcess International’s March 2011 Supplement, this groundbreaking roundtable will:
• Educate the bioprocess and cell therapy market (suppliers and end-users) on the similarities and differences between the two processes;
• Educate and encourage the investor community to keep increasing their interest and investment;
• Expedite the commercialization process.

***Open to Full and One Day Tuesday Conferees, Designated exhibitors and Speakers.   Ticket required.
Speaker:
Dominic Clarke - Product Manager, Stem-Cell Freezing, Charter Medical
Robert Perry, Athersys
Robert Preti - President & CSO, Progenitor Cell Therapy, LLC
Jon Rowley, Lonza
Moderator:
Anne Montgomery - Editor in Chief, BioProcess International
Bob Speziale - Vice President, Business Development, Invetech
Wednesday, March 30, 2011
Suggest A Question for this Session
Vaccines ' Enabling Technologies for Biotechnology's Brave New World
Room: 1E18, 1E19, 1E20 ~ 12:30 pm - 2:00 pm (Wednesday, March 30, 2011)
Presented by:

Sponsored By: BioProcess International

As the need for new generations of vaccines are needed to battle a new generation of threats, the world looks to the biotechnology industry to increase both speed of production and specificity of vaccines.

Increased understanding of human immunology combined with new technologies, production platforms and process innovations provide vaccine developers with access to proven options unknown to previous generations.

A preview to BioProcess International’s September 2011 supplement, this roundtable will:

• Recap the history of vaccines
• Discuss the need to balance philanthropy and profitability
• Introduce the latest technological innovations and challenges
• Preview the continuing work towards pandemic preparedness

***Open to Full and One Day Wednesday Conferees, Designated exhibitors and Speakers. Ticket required.
Speaker:
Peter Latham - Co-Founder, President, BioPharm Services US
Magda Marquet, Althea Technologies
James Wilkins - Chief Technology Officer, Sensorin
Moderator:
Anne Montgomery - Editor in Chief, BioProcess International

Quick Search

You can use the search box below to locate specific speakers or sessions.



View Options

View By Track

View By Day

View All

Reed Exhibitions
  • Pharmaceuticals
  • Biologics
  • Generics
  • Contract Services
ConferencePath System © 2004 - 2014 ConferencePath & MasseyMedia. All Rights Reserved.